SM
BIOC
Sabby Management’s Biocept, Inc. BIOC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-29,602
| Closed | -$10.1K | – | 102 |
|
|
2023
Q1 | $10.1K | Sell |
29,602
-900
| -3% | -$306 | 0.01% | 70 |
|
|
2022
Q4 | $16.2K | Hold |
30,502
| – | – | 0.01% | 79 |
|
|
2022
Q3 | $28K | Hold |
30,502
| – | – | 0.04% | 70 |
|
|
2022
Q2 | $29K | Hold |
30,502
| – | – | 0.02% | 71 |
|
|
2022
Q1 | $71K | Buy |
30,502
+11,838
| +63% | +$27.6K | 0.01% | 76 |
|
|
2021
Q4 | $68K | Buy |
+18,664
| New | +$68K | 0.01% | 94 |
|
|
2021
Q3 | – | Sell |
-76,892
| Closed | -$322K | – | 140 |
|
|
2021
Q2 | $322K | Buy |
76,892
+15,428
| +25% | +$64.6K | 0.05% | 65 |
|
|
2021
Q1 | $313K | Buy |
61,464
+29,886
| +95% | +$152K | 0.06% | 63 |
|
|
2020
Q4 | $140K | Buy |
+31,578
| New | +$140K | 0.03% | 47 |
|
|
2019
Q1 | – | Sell |
-57,505
| Closed | -$49K | – | 110 |
|
|
2018
Q4 | $49K | Sell |
57,505
-84,912
| -60% | -$72.4K | 0.01% | 68 |
|
|
2018
Q3 | $392K | Sell |
142,417
-35,184
| -20% | -$96.8K | 0.05% | 44 |
|
|
2018
Q2 | $36K | Buy |
177,601
+85,227
| +92% | +$17.3K | 0.01% | 73 |
|
|
2018
Q1 | $27K | Sell |
92,374
-869,891
| -90% | -$254K | ﹤0.01% | 84 |
|
|
2017
Q4 | $668K | Buy |
+962,265
| New | +$668K | 0.06% | 36 |
|
|
2017
Q1 | – | Sell |
-411,432
| Closed | -$319K | – | 209 |
|
|
2016
Q4 | $319K | Buy |
+411,432
| New | +$319K | 0.02% | 108 |
|